Bussiness3 months ago
Baxter strikes $3.8B agreement to sell kidney care business to Carlyle Group
Baxter (NYSE: BAX) + announced today that it entered into a definitive agreement under which Carlyle Group acquires its Kidney Care business. In January 2023, Baxter announced...
